Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The IL-8, VEGF, and CFH polymorphisms and bevacizumab in age-related macular degeneration.

Ophthalmology - 1 Apr 2014

Hautamäki Asta, Kivioja Jarno, Seitsonen Sanna, Savolainen Eeva-Riitta, Liinamaa M Johanna, Luoma Arto, Järvelä Irma, Immonen Ilkka

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Bevacizumab
Share to Coloring Agents
Share to Complement Factor H

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorescein Angiography

Share to Interleukin-8

Share to Tomography, Optical Coherence

Share to Wet Macular Degeneration

Source

Identifiers

PMID: 24534755
DOI: 10.1016/j.ophtha.2013.11.035

Genes

CFH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The IL-8, VEGF, and CFH polymorphisms and bevacizumab in age-related macular degeneration.PMID 24534755Read ↗

CFH, VEGF, and PEDF genotypes and the response to intravitreous injection of bevacizumab for the treatment of age-related macular degenerationSemantic proximity Read ↗

Genetic markers of the effectiveness of anti-VEGF therapy in age-related macular degenerationSemantic proximity Read ↗

Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis.Semantic proximity Read ↗

Associations of TLR4 and IL-8 genes polymorphisms with Age-related macular degeneration (AMD): a systematic review and meta-analysisSemantic proximity Read ↗

Genetic variants and serum biomarkers of CXCL8, MAP3K7, LTA/TNF, EXOC3L1, PROCR, and TRAF2 in Age-Related macular degeneration: associations with disease risk and therapeutic response.Semantic proximity Read ↗

Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration.Semantic proximity Read ↗

Associations of microRNAs, Angiogenesis-Regulating Factors and CFH Y402H Polymorphism-An Attempt to Search for Systemic Biomarkers in Age-Related Macular Degeneration.Semantic proximity Read ↗

Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.Semantic proximity Read ↗

The Impact of ARMS2 (rs10490924), VEGFA (rs3024997), TNFRSF1B (rs1061622), TNFRSF1A (rs4149576), and IL1B1 (rs1143623) Polymorphisms and Serum Levels on Age-Related Macular Degeneration Development and Therapeutic Responses.Semantic proximity Read ↗

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration.Semantic proximity Read ↗

CFH (rs1061170, rs1410996), KDR (rs2071559, rs1870377) and KDR and CFH Serum Levels in AMD Development and Treatment EfficacySemantic proximity Read ↗

Roles of three common VEGF polymorphisms in the risk of age-related macular degeneration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.